SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GAVIOLI, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.012
AS - Asia 7.210
EU - Europa 4.433
SA - Sud America 1.064
Continente sconosciuto - Info sul continente non disponibili 217
AF - Africa 158
OC - Oceania 18
Totale 28.112
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.658
SG - Singapore 2.794
CN - Cina 1.813
BR - Brasile 836
VN - Vietnam 821
PL - Polonia 765
IT - Italia 720
UA - Ucraina 685
DE - Germania 618
HK - Hong Kong 561
GB - Regno Unito 445
TR - Turchia 409
FI - Finlandia 268
FR - Francia 245
SE - Svezia 229
CA - Canada 173
RU - Federazione Russa 149
BD - Bangladesh 146
IN - India 141
JP - Giappone 134
MX - Messico 109
AR - Argentina 88
ID - Indonesia 83
BE - Belgio 72
NL - Olanda 66
ZA - Sudafrica 59
IQ - Iraq 52
ES - Italia 39
PK - Pakistan 35
CO - Colombia 32
VE - Venezuela 29
LT - Lituania 25
MY - Malesia 25
PH - Filippine 25
CL - Cile 24
MA - Marocco 23
SA - Arabia Saudita 23
EC - Ecuador 22
UZ - Uzbekistan 22
AE - Emirati Arabi Uniti 20
JM - Giamaica 19
AU - Australia 18
IR - Iran 17
TN - Tunisia 17
CZ - Repubblica Ceca 16
PY - Paraguay 16
AT - Austria 15
AL - Albania 12
JO - Giordania 12
KE - Kenya 12
CR - Costa Rica 11
IE - Irlanda 11
DZ - Algeria 10
EG - Egitto 9
OM - Oman 9
TT - Trinidad e Tobago 9
PA - Panama 8
PE - Perù 8
RO - Romania 8
KR - Corea 7
LB - Libano 7
SN - Senegal 7
KZ - Kazakistan 6
MD - Moldavia 6
NP - Nepal 6
UY - Uruguay 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
GR - Grecia 5
IL - Israele 5
KG - Kirghizistan 5
NI - Nicaragua 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
LY - Libia 4
RS - Serbia 4
TH - Thailandia 4
TW - Taiwan 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
AZ - Azerbaigian 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
PR - Porto Rico 3
SV - El Salvador 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
HU - Ungheria 2
LK - Sri Lanka 2
MT - Malta 2
NO - Norvegia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 27.876
Salva come PNG Salva come JPEG
Città #
Singapore 1.769
Ashburn 1.624
Fairfield 1.283
Woodbridge 1.108
San Jose 949
Houston 898
Warsaw 757
Jacksonville 731
Ann Arbor 726
Chandler 684
Beijing 616
Santa Clara 599
Hong Kong 548
Seattle 515
Wilmington 456
Cambridge 439
Council Bluffs 356
Dallas 309
Los Angeles 277
Ho Chi Minh City 258
Ferrara 233
Izmir 231
New York 219
Hanoi 207
Nanjing 181
Munich 154
Princeton 149
San Diego 145
Tokyo 130
Lauterbourg 129
Milan 114
Boardman 109
São Paulo 92
Shanghai 91
Helsinki 83
The Dalles 79
Buffalo 78
Mexico City 75
Brussels 70
Shenyang 68
Hefei 63
Nanchang 56
Montreal 55
London 53
Toronto 53
Orem 51
Turku 50
Dearborn 49
Bologna 48
Jakarta 47
Tianjin 47
Addison 45
San Mateo 45
Chicago 44
Da Nang 43
Haiphong 43
Changsha 42
Hebei 42
Bremen 38
Boston 37
Brooklyn 37
Jinan 37
Atlanta 36
Chennai 36
Falls Church 36
Phoenix 36
Frankfurt am Main 33
San Francisco 33
Jiaxing 31
Stockholm 30
Amsterdam 29
Johannesburg 28
Rome 28
Mountain View 27
Porto Alegre 27
Rio de Janeiro 27
Guangzhou 26
Denver 25
Manchester 25
Dong Ket 23
Falkenstein 23
Poplar 23
Auburn Hills 21
Moscow 21
Columbus 20
Tashkent 20
Belo Horizonte 19
Philadelphia 19
Zhengzhou 19
Norwalk 18
Brasília 17
Des Moines 17
Dhaka 17
Modena 17
Ningbo 17
Ardabil 16
Baghdad 16
Redwood City 16
Ankara 15
Istanbul 15
Totale 19.466
Salva come PNG Salva come JPEG
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 418
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 372
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 295
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 281
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 277
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 271
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 268
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 263
Nafion®-containing solid lipid nanoparticles as a tool for anticancer pt delivery: preliminary studies 258
Arecoline tripeptide inhibitors of proteasome 257
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 249
Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity 249
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 246
Association between different anti-Tat antibody isotypes and HIV disease progression: Data from an African cohort 243
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19 240
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 238
Biologically active platinum complexes containing 8-thiotheophylline and 8-(methylthio)theophylline 238
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 230
Synthesis and biological evaluation of diastereoisomerically pure N,O-nucleosides 230
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 230
Modulation of neutrophil functions by activated platelet release factors 227
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors 224
"Lab-on-a-Chip" devices for cellular array based on dielectrophoresis 222
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 221
Phosphinic platinum complexes with 8-thiotheophylline derivatives: Synthesis, characterization, and antiproliferative activity 220
Vinyl ester-based cyclic peptide proteasome inhibitors 219
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 218
Deficiency of neutrophil membrane antigen detected by monoclonal antibody in rheumatoid arthritis 217
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 217
Rational design of nucleoside-bile acid conjugates incorporating a triazole moiety for anticancer evaluation and SAR exploration 217
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 216
Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8 214
An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins 213
New class of proteasome 20S inhibitors: a crystallographic and molecular modelling study 213
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 212
UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion 212
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 212
Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells 211
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 210
Attivita' tumoricida dei neutrofili 209
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 209
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 208
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 205
Dual mechanism in induction of human neutrophil cytotoxicity: Activation of protein kinase C and elevation in intracellular calcium 204
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 204
A new approach to UV protection by direct surface functionalization of TiO2 with the antioxidant polyphenol dihydroxyphenyl benzimidazole carboxylic acid 204
Platinum and ruthenium complexes of new long-tail derivatives of PTA (1,3,5-triaza-7-phosphaadamantane): Synthesis, characterization and antiproliferative activity on human tumoral cell lines 201
Different expression of Blimp-1 in HIV infection may be used to monitor disease progression and provide a clue to reduce immune activation and viral reservoirs 201
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (ii) carboxylates 200
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 198
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 198
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 197
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 195
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 194
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 193
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans 193
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 192
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120 191
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 189
ANTI-INFLAMMATORY AGENTS INHIBIT NEUTROPHIL CYTOTOXIC ACTIVITY TOWARDS ERYTHROLEUKEMIC HUMAN CELLS 188
Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2 187
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 186
Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells 185
CULTURED HUMAN FIBROBLASTS ACQUIRE ADHESIVENESS FOR NEUTROPHILS AFTER STIMULATION 184
Novel oleanolic vinyl boronates: synthesis and antitumor activity 184
null 183
"Lethal kiss” on a dielectrophoresis (DEP) based Lab-on-a-chip device: two-colour real-time determination of cytotoxic T-lymphocyte activity. 183
The Enigma of Tripeptidyl-Peptidase II: Dual Roles in Housekeeping and Stress 181
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 180
ACTION MECHANISM OF ACTIVATORS OF NEUTROPHIL-MEDIATED CYTOTOXICITY 179
null 179
ACTIVATED HUMAN FIBROBLASTS ADHERE TO NEUTROPHILS 177
HLA B51 antigen associated with neutrophil hyper-reactivity 176
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TOWARDS LINEAR AND CYCLIC PEPTIDE T ANALOG 175
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 174
Expression and functionality of adenosine receptors in human blood cells 173
Expression and functional A3 adenosine receptors in human lymphocytes 173
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 172
Dielectrophoresis (DEP) based Lab-on-a-chip devices for real-time monitoring of the activity of cytotoxic T-lymphocytes. 172
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 171
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 171
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 168
Expression of functional A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. 167
null 167
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 162
Vaccines containing the HIV tat protein as an adjuvant for the enhancement of cytotoxic T-cell responses 162
Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit 161
alpha,beta-Unsaturated Carbonyl System of Chalcone-Based Derivatives Is Responsible for Broad Inhibition of Proteasomal Activity and Preferential Killing of Human Papilloma Virus (HPV) Positive Cervical Cancer Cells 160
The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity 159
ACTIVATION OF NEUTROPHIL CYTOTOXICITY BY SYNERGISTIC ACTION OF TPA AND TARGET IMMUNIZATION 156
New cyclic peptide proteasome inhibitors 156
HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors 155
Triggering of neutrophil cytotoxicity against an antibody-coated tumour target by TPA 153
Recent Advances In The Development Of HIV-1 Tat-Based Vaccines 152
c-Myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells 152
Protein kinase C mediates human neutrophil cytotoxicity 150
HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population 150
NEUTROPHIL CR1 RECEPTOR: RELATIONSHIP BETWEEN EXPRESSION LEVEL AND CYTOTOXICITY IN HEALTHY AND CHRONIC MYELOID LEUKEMIA 148
Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides 147
Immune escape by Epstein-Barr virus (EBV) carrying burkitt's lymphoma: In vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells 146
Totale 20.357
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 975
Totale 123.208
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.723 0 158 154 112 93 58 116 96 75 119 151 591
2022/20231.594 168 84 78 215 254 230 84 133 192 10 84 62
2023/2024816 80 126 34 27 50 151 35 61 11 22 17 202
2024/20253.436 82 78 290 162 442 303 64 176 580 339 512 408
2025/202610.003 1.093 344 987 1.212 1.416 737 1.227 531 895 1.019 404 138
2026/2027741 284 457 0 0 0 0 0 0 0 0 0 0
Totale 28.112